Search clinical trials for: Low molecular Weight Heparin

Total 124874 results

First Affiliated Hospital of Chongqing Medical...

Completed

Efficacy and Safety of Short-term Postoperative Anticoagulant Therapy to Prevente Thrombosis in Arterovenous Fistula (EASOAT)

Thrombosis

China
Jesper Kjaergaard
Zealand University Hospital; Copenhagen University Hospital at Herlev

Active, not recruiting

Percutaneous Embolectomy, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY-II)

Pulmonary Embolism

Denmark
Uma Borate

Suspended

Gentuzumab Ozogamicin and Midostaurin Combination With Standard Cytarabine and Danunorubi Midostaurin as a Novel Approach to Treating Patients With Newly Diagnosed FLT-3 Mutated Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States
University of Melbourne
Australian and New Zealand Intensive Care Research Centre; The Peter Doherty... and other collaborators

Active, not recruiting

Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial (ASCOT)

SARS-CoV-2 Infection (COVID-19)

Australia
Major Extremity Trauma Research Consortium
Patient-Centered Outcomes Research Institute

Completed

PREVENTion of Clot in Orthopaedic Trauma (PREVENT CLOT)

Trauma | Blood Clot

United States, Canada
Fundació Sant Joan de Déu
Servicio de Asesoría a la Investigación y Logística SL

Completed

Treatment of Intrauterine Growth Restriction With Low Molecular Heparin. (TRACIP)

Intrauterine Growth Restriction

Spain
Pfizer

Completed

Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer

Cancer

United States, Canada, Spain, Austria, Netherlands
Uskudar University

Completed

Effect of Hypericum Perforatum Oil on Ecchymosis and Pain

Pain | Ecchymosis

Turkey
Matthew Neal MD
National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE (ACTIV-4A)

Covid19

United States, Spain, Brazil, Italy
Sunnybrook Health Sciences Centre
LEO Pharma; Sunnybrook Research Institute

Terminated

Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome (TILE)

Deep Vein Thrombosis | Post Thrombotic Syndrome

Canada
Chen Ying

Enrolling by invitation

Efficacy of Anisodamine Hydrobromide Combined With Low-molecular-weight Heparin in the Treatment of Patients With Sepsis

Sepsis

China
University Hospital Ostrava

Completed

Monitoring Anticoagulation in Patients on ECMO for Severe Lung Failure

COVID-19 | ARDS

Czechia
Assistance Publique - Hôpitaux de Paris
LEO Pharma

Completed

Therapeutic Anticoagulation Strategy for Acute Chest Syndrome (TASC)

Anemia | Acute Chest Syndrome | Sickle Cell | Low-Molecular-Weight Heparin

France
Ottawa Hospital Research Institute
Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR)...

Terminated

WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism (WAVe)

Obesity | Cancer | Venous Thromboembolism

Canada
Northern Jiangsu People's Hospital

Completed

Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection (ESAPT)

Venous Thrombosis | Cirrhosis | Hypertension, Portal | Splenectomy

China
Northern Jiangsu People's Hospital

Completed

Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）

Venous Thrombosis | Cirrhosis | Hypertension, Portal | Splenectomy; Status

China
Alexandria University

Completed

Efficacy of 5-fluorouracil and Low Molecular Weight Heparin in High-risk Pediatric Retinal Detachment

Retinal Detachment | Proliferative Vitreoretinopathy

Egypt
Bayer
Janssen Research & Development, LLC

Completed

A Study to Gather Information About Rivaroxaban in Patients in Sweden With Cancer Who Also Have Thrombosis (OSCAR-SE)

Treatment of Venous Thromboembolism in Cancer Patients

Sweden
Bayer

Completed

Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort (OSCAR-US)

Treatment of Venous Thromboembolism in Cancer Patients | Prophylaxis of Recurrent Venous Thromboembolism in Cancer Patients

United States
Kastamonu University

Completed

Low-Molecular-Weight Heparin Injection in Stroke Patients

Stroke

Turkey
Alliance Foundation Trials, LLC.
Patient-Centered Outcomes Research Institute

Completed

Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer (CANVAS)

Cancer | Venous Thromboembolism | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE) | Blood Clot

United States
Central Hospital, Nancy, France
Ministry of Health, France; University Hospital of Saint-Etienne; Grand Est Region

Completed

Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19 (COVI-DOSE)

Thrombosis | Deep Vein Thrombosis | COVID | Pulmonary Embolism

France
American University of Beirut Medical Center

Completed

Low Molecular Weight Heparin to Improve Pregnancy Outcome in Patients With Recurrent Implantation Failure (BRIF)

Sterility

Lebanon
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States
Karolinska Institutet

Completed

Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients

Covid19 | Thromboembolism

Sweden
Universitätsklinikum Hamburg-Eppendorf

Completed

Hamburg Edoxaban for Anticoagulation in COVID-19 Study (HERO-19)

Covid19

Germany
CHAD

Terminated

The Portuguese Survey on Anticoagulated Patients Register (START-Portugal-Register) (START-Portugal)

Atrial Fibrillation | Venous Thromboembolism | Heart Valve Diseases or Prosthesis

Portugal
University Hospital, Ghent

Completed

Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.

COVID-19 | Critical Illness | Deep Vein Thrombosis | Anticoagulants and Bleeding Disorders

Belgium
University of Chicago

Active, not recruiting

Diffusion of Use of Low Molecular Weight Heparin for Thrombosis on the Medicine Services

Thrombosis

United States
Tampere University Hospital
Heart Hospital, Tampere University Hospital

Completed

: Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery

Venous Thromboembolism | Pulmonary Embolism | Thromboprophylaxis

Finland
Yuksek Ihtisas University
Saglik Bilimleri Universitesi

Completed

Cold Application on the Subcutaneous Injection

Pain | Injection Site Bruising | Bruising
Damascus University
Unipharma, HamaPharma, Almujtahed hospital

Completed

Rivaroxaban vs. Warfarin in CVT Treatment (RWCVT)

Cerebral Vein Thrombosis

Syrian Arab Republic
Military Institute of Medicine, Poland

Terminated

Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome. (ENOX-inNS)

Nephrotic Syndrome

Poland
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France; National Cancer Institute, France

Terminated

Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE) (PROVE)

Venous Thromboembolism | Lung Neoplasm

France
HaEmek Medical Center, Israel

Completed

anti10a Levels in Women Treated With LMWH in the Postpartum Period

Venous Thromboembolism

Israel
G. d'Annunzio University

Completed

Low Molecular Weight Heparin vs Unfractionated Heparin at Cardiac Surgery

Coronary Disease | Coronary Artery Bypass Grafting

Italy
Azidus Brasil
Blau Farmaceutica S.A.

Completed

Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Intravenous Administration

Healthy

Brazil
Azidus Brasil

Completed

Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Subcutaneous Single Dose

Healthy

Brazil
Bristol-Myers Squibb
Pfizer; Pediatric Heart Network

Completed

A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation

Thrombosis

United States, Spain, Russian Federation, Argentina, Australia, Austria, Brazil, Canada, Finland, Germany, Israel, Italy, Mexico, United Kingdom
Hospital Universitario Infanta Leonor

Completed

Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID)

Covid19 | Thrombosis

Spain
Faculdade de Medicina do ABC

Completed

Effect of Prophylatic Use of Enoxaparin in Women Undergoing in Vitro Fertilization Treatment

Thrombophilia | Infertility, Female | Fertilization in Vitro

Brazil
Assistance Publique - Hôpitaux de Paris

Completed

ANTIcoagulation in Severe COVID-19 Patients (ANTICOVID)

Severe COVID-19 Pneumonia

France
Roswell Park Cancer Institute
Pfizer

Completed

Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery

Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Renal Cell Cancer | Clear Cell Sarcoma of the Kidney

United States, Netherlands
National Cancer Institute (NCI)

Completed

Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer

Advanced Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v7 | Stage IV Renal Cell Cancer AJCC v7 | Advanced Sarcomatoid Renal Cell Carcinoma

United States
Fundación de investigación HM
Syntax for Science, S.L

Terminated

Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19

Covid-19

Spain
Academisch Medisch Centrum - Universiteit van Amsterdam...
Netherlands Organisation for Scientific Research; Aspen Pharma; CHU of Saint... and other collaborators

Completed

Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy (Highlow)

Pulmonary Embolism | Deep Venous Thrombosis

Norway, Netherlands, Denmark, France, Belgium, Ireland, United States, Canada, Russian Federation, Spain
Medical College of Wisconsin
Ohio State University; Versiti

Completed

Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis

Neoplasms | Venous Thrombosis

United States
Thrombosis Research Institute
Sanofi

Terminated

Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients (ETHIC)

COVID-19

Australia, Belgium, South Africa
Bayer

Completed

Study to Compare the Effectiveness of Rivaroxaban (Xarelto) Versus Low-molecular-weight Heparin (LMWH) and Phenprocoumon for the Treatment and Secondary Prevention of Venous Thromboembolism in Routine Clinical Practice in Germany

Venous Thromboembolism

Germany
Universitätsklinikum Köln
German Research Foundation; The Clinical Trials Centre Cologne; Pharmacy of the... and other collaborators

Completed

Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment. (PRIVENT)

Rhegmatogenous Retinal Detachment | High-risk for Proliferative Vitreoretinopathy (PVR)

Germany

Search clinical trials for: Low molecular Weight Heparin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations